Doctor profile · Federal record
Dr. Manjula Nagaraja, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Internal Medicine Physician · Pulmonary Disease Physician · Raleigh, NC
- NPI 1770873044
- Accepts Medicare
- 15 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3000 New Bern Ave
Raleigh, NC 276101231
(919) 235-6450 - Mailing address
-
2920 Highwoods Blvd
Raleigh, NC 276040010
Credentials & registration
- NPI registered
- April 2011 — 15 yrs on file
- Profile last updated
- March 9, 2021
- Year of graduation
- 2011 — 15 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State licenses (2)
- North Carolina #2018-00767 · Pennsylvania #MD460282
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770873044. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,239
Distinct HCPCS
10
Medicare allowed
$81,004
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 330 | 207 | $122 | |
J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 291 | 97 | $0 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 113 | 113 | $158 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 98 | 95 | $36 | |
94726 |
Test to determine lung volumes using sensors | 85 | 80 | $51 | |
94729 |
Test to examine how well the lungs exchange gases | 85 | 81 | $54 | |
94010 |
Test to measure expiratory airflow and volume | 53 | 50 | $25 | |
94618 |
Test for exercise-induced lung stress | 53 | 45 | $32 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 37 | 31 | $120 | |
94664 |
Evaluation of use of breathing device | 24 | 23 | $16 |
In context: peer comparison
Among 10 peers in Raleigh Pulmonary Disease Physician, average services per provider: 72. This provider delivers 17× the peer median.Open Payments
Industry payments received
All-time total
$369
Transactions
14
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 9 | $155.40 | |
| Pulmonx Corporation | 1 | $146.33 | |
| Genzyme Corporation | 3 | $50.18 | |
| Inogen, INC. | 1 | $17.16 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,584
Patients
531
Total drug cost
$672,619
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 410 | 93 | $327,925 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 235 | 82 | $101,786 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 191 | 98 | $5,718 |
| Prednisone | Generic | 108 | 71 | $603 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 99 | 44 | $50,180 |
| Azithromycin | Generic | 85 | 29 | $1,241 |
| Montelukast Sodium | Generic | 77 | 27 | $1,254 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 62 | 16 | $38,913 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 61 | 11 | $34,968 |
| Advair Hfa (Fluticasone Propion/Salmeterol) | Brand | 57 | 16 | $25,823 |
Hospital affiliations
Frequently asked questions
What is Dr. Manjula Nagaraja's medical specialty?
Dr. Manjula Nagaraja practices Pulmonary Disease Physician in Raleigh, NC.
Where does Dr. Manjula Nagaraja practice?
Dr. Manjula Nagaraja practices at 3000 New Bern Ave, Raleigh, NC 276101231. Office phone: 9192356450.
What is Dr. Manjula Nagaraja's NPI?
Dr. Manjula Nagaraja's National Provider Identifier (NPI) is 1770873044, issued by NPPES.
Does Dr. Manjula Nagaraja accept Medicare assignment?
Yes. Dr. Manjula Nagaraja accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Manjula Nagaraja commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg (HCPCS J7613); New patient office or other outpatient visit (HCPCS 99204). Source: CMS Medicare Physician & Other Practitioners file.